Novel subcellular localization for α-synuclein: Possible functional consequences

Frontiers in Neuroanatomy

Volumn 9, Issue FEB, 2015, Pages 1-7

  Guardia Laguarta, Cristina ^a   Area Gomez, Estela ^a   Schon, Eric A ^a   Przedborski, Serge ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Alpha synuclein; Endoplasmic reticulum; Mitochondria associated membranes; Parkinson's disease; Phospholipid

Indexed keywords

ALPHA SYNUCLEIN; CHOLESTEROL ACYLTRANSFERASE; GAMMA SECRETASE; PHOSPHOLIPID; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CALCIUM HOMEOSTASIS; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CONFOCAL MICROSCOPY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE MUTATION; HUMAN; LIPID OXIDATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SYNAPTIC MEMBRANE;

EID: 84923276705     PISSN: 16625129     EISSN: 16625129     Source Type: Journal    
DOI: 10.3389/fnana.2015.00017     Document Type: Review

References (104)

1. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W. H., Castillo, P. E., et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.doi:10.1016/s0896-6273(00)80886-7
2. Area-Gomez, E., de Groof, A. J. C., Boldogh, I., Bird, T. D., Gibson, G. E., Koehler, C. M., et al. (2009). Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am. J. Pathol. 175, 1810-1816.doi:10.2353/ajpath.2009.090219
3. Area-Gomez, E., Del Carmen Lara Castillo, M., Tambini, M. D., GuardiaLaguarta de Groof, A. J. C., Madra, M., et al. (2012). Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J. 31, 4106-4123.doi:10.1038/emboj.2012.202
4. Auluck, P. K., Caraveo, G., and Lindquist, S. (2010). a-Synuclein: Membrane interactions and toxicity in Parkinson’s disease. Annu. Rev. Cell Dev. Biol. 26, 211-233.doi:10.1146/annurev.cellbio.042308.113313
5. Baloh, R. H., Schmidt, R. E., Pestronk, A., and Milbrandt, J. (2007). Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J. Neurosci. 27, 422-430.doi:10.1523/jneurosci.4798-06.2007
6. Bar-On, P., Crews, L., Koob, A. O., Mizuno, H., Adame, A., Spencer, B., et al. Statins reduce neuronal alpha-synuclein aggregation in in vitro models ofParkinson’s disease. J. Neurochem. 105, 1656-1667.doi:10.1111/j.1471-4159.2008.05254.x
7. Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38, 515-517.doi:10.1038/ng1769
8. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features ofParkinson’s disease. Nat. Neurosci. 3, 1301-1306.doi:10.1038/81834
9. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A. I., Jansen Steur, E. N. H., and Braak, (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197-211.doi:10.1016/s0197-4580(02)00065-9
10. Bui, M., Gilady, S. Y., Fitzsimmons, R. E. B., Benson, M. D., Lynes, E. M., Gesson, K., et al. (2010). Rab32 modulates apoptosis onset and Mitochondria- Associated Membrane (MAM) properties. J. Biol. Chem. 285, 31590-31602.doi:10.1074/jbc.M110.101584
11. Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., et al. (2002). Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
12. Call, T., Ottolini, D., Negro, A., and Brini, M. (2012). a-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum- mitochondria interactions. J. Biol. Chem. 287, 17914-17929.doi:10.1074/jbc.M111.302794
13. Call, T., Ottolini, D., Negro, A., and Brini, M. (2013). Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics. Biochim. Biophys. Acta 1832, 495-508.doi:10.1016/j.bbadis.2013.01.004
14. Chan, D.C. (2006). Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 22, 79-99.doi:10.1146/annurev.cellbio.22.010305.104638
15. Chen, H., and Chan, D. C. (2009). Mitochondrial dynamics-fusion, fission, movement and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 18, R169-R176.doi:10.1093/hmg/ddp326
16. Chinta, S.J., Mallajosyula, J. K., Rane, A., andAndersen, J. K.(2010). Mitochondrial a-synuclein accumulation impairs complexI function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486, 235-239.doi:10.1016/j.neulet.2010.09.061
17. Choubey, V., Safiulina, D., Vaarmann, A., Cagalinec, M., Wareski, P., Kuum, M., et al. (2011). Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J. Biol. Chem. 286, 10814-10824.doi:10.1074/jbc.M110.132514
18. Chu, Y., and Kordower, J. H. (2007). Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson’s disease? Neurobiol. Dis. 25, 134-149.doi:10.1016/j.nbd.2006.08.021
19. Ciarlo, L., Manganelli, V., Garofalo, T., Matarrese, P., Tinari, A., Misasi, R., et al. Association of fission proteins with mitochondrial raft-like domains. CellDeathDiffer. 17, 1047-1058.doi:10.1038/cdd.2009.208
20. Cole, N. B., Dieuliis, D., Leo, P., Mitchell, D. C., and Nussbaum, R. L. (2008). Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp. Cell Res. 314, 2076-2089.doi:10.1016/j.yexcr.2008.03.012
21. Cole, N.B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R. L. (2002). Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein. J. Biol. Chem. 277, 6344-6352.doi:10.1074/jbc.m108414200
22. Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., et al. (2012). Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease. Sci. Transl. Med. 4:141ra90.doi:10.1126/scitranslmed.3003985
23. Csordas, G., and Hajnoczky, G. (2009). SR/ER-mitochondrial local communication: Calcium and ROS. Biochim. Biophys. Acta 1787, 1352-1362.doi:10.1016/j.bbabio.2009.06.004
24. Csordas, G., Renken, C., Varnai, P., Walter, L., Weaver, D., Buttle, K. F., et al. (2006). Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 174, 915-921.doi:10.1083/jcb.200604016
25. Csordas, G., Varnai, P., Golenar, T., Roy, S., Purkins, G., Schneider, T. G., et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 39, 121-132.doi:10.1016/j.molcel.2010.06.029
26. Dalfo, E., Portero-Otin, M., Ayala, V., Martinez, A., Pamplona, R., and Ferrer, (2005). Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J. Neuropathol. Exp. Neurol. 64, 816-830.doi:10.1097/01.jnen.0000179050.54522.5a
27. Dauer, W., and Przedborski, S. (2003). Parkinson’s disease: Mechanisms and models. Neuron 39, 889-909.doi:10.1016/S0896-6273(03)00568-3
28. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998). Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.doi:10.1074/jbc.273.16.9443
29. de Brito, O. M., and Scorrano, L. (2008). Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456, 605-610.doi:10.1038/nature07534
30. de Brito, O. M., andScorrano, L. (2010). An intimate liaison: Spatial organization of the endoplasmic reticulum-mitochondriarelationship. EMBO J. 29, 2715-2723.doi:10.1038/emboj.2010.177
31. De Franceschi, G., Frare, E., Bubacco, L., Mammi, S., Fontana, A., and de Laureto, P. P. (2009). Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid. J. Mol. Biol. 394, 94-107.doi:10.1016/j.jmb.2009.09.008
32. de Lau, L. M. L., Koudstaal, P. J., Hofman, A., and Breteler, M. M. B. (2006). Serum cholesterol levels and the risk of Parkinson’s disease. Am. J. Epidemiol. 164, 998-1002.doi:10.1093/aje/kwj283
33. Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., and Anandatheerthavarada, H. K. (2008). Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100.doi:10.1074/jbc.M710012200
34. Eliezer, D., Kutluay, E., Bussell, R., and Browne, G. (2001). Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073.doi:10.1006/jmbi.2001.4538
35. Elkon, H., Don, J., Melamed, E., Ziv, I., Shirvan, A., and Offen, D. (2002). Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome Coxidase. J. Mol. Neurosci. 18, 229-238.doi:10.1385/jmn:18:3:229
36. Fabelo, N., Martin, V., Santpere, G., Marin, R., Torrent, L., Ferrer, I., et al.. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson’s disease and incidental Parkinson’s disease. Mol. Med. 17,1107-1118.doi:10.2119/molmed.2011.00119
37. Fantini, J., and Yahi, N. (2013). The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: Key role of ganglioside-and cholesterol-binding domains. Adv. Exp. Med. Biol. 991, 15-26.doi:10.1007/978-94-007-6331-9_2
38. Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D., and Edwards, R. H. (2004). Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24, 6715-6723.doi:10.1523/jneurosci.1594-04.2004
39. Friedman, J. R., Lackner, L. L., West, M., DiBenedetto, J. R., Nunnari, J., and Voeltz, G. K. (2011). ER tubules mark sites of mitochondrial division. Science 334, 362.doi:10.1126/science.1207385
40. Galvin, J. E., Uryu, K., Lee, V. M., and Trojanowski, J. Q. (1999). Axon pathologyin Parkinson’s disease and Lewy body dementia hippocampus contains a-, - and Y-synuclein. Proc. Natl. Acad. Sci. USA 96, 13450-13455.doi:10.1073/pnas.96.23.13450
41. Garofalo, T., Giammarioli, A. M., Misasi, R., Tinari, A., Manganelli, V., Gambardella, L., et al. (2005). Lipid microdomains contribute to apoptosis- associatedmodifications ofmitochondriain T cells. CellDeathDiffer. 12, 1378-1389.doi:10.1038/sj.cdd.4401672
42. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., et al. (2008). The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA 105, 145-150.doi:10.1073/pnas.0710685105
43. Goldberg, M.S., and Lansbury, P. T. (2000). Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nat. CellBiol. 2, E115-E119.doi:10.1038/35017124
44. Guardia-Laguarta, C., Area-Gomez, E., Rub, C., Liu, Y., Magrane, J., Becker, etal.(2014).a-Synucleinislocalizedtomitochondria-associatedERmembranes. J.Neurosci.34,249-259.doi:10.1523/JNEUR0SCI.2507-13.2014
45. Hamasaki, M., Furuta, N., Matsuda, A., Nezu, A., Yamamoto, A., Fujita, N., et al. (2013). Autophagosomes form at ER-mitochondria contact sites. Nature 495, 389-393.doi:10.1038/nature11910
46. Hayashi, T., and Fujimoto, M. (2010). Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum- mitochondria junction. Mol. Pharmacol. 77, 517-528.doi:10.1124/mol.109.062539
47. Hayashi, T., Rizzuto, R., Hajnoczky, G., and Su, T. P. (2009). MAM: More thanjust a housekeeper. Trends Cell Biol. 19, 81-88.doi:10.1016/j.tcb.2008.12.002
48. Hodge, T., and Colombini, M. (1997). Regulation of metabolite flux through voltage-gating of VDAC channels. J. Membr. Biol. 157, 271-279.doi:10.1007/s002329900235
49. Hsu, L.J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., et al. (2000). a-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157, 401-410.doi:10.1016/s0002-9440(10)64553-1
50. Hu, G., Antikainen, R., Jousilahti, P., Kivipelto, M., and Tuomilehto, J. (2008). Total cholesterol and the risk of Parkinson disease. Neurology 70, 1972-1979.doi:10.1212/01.wnl.0000312511.62699.a8
51. Huang, X., Chen, H., Miller, W. C., Mailman, R. B., Woodard, J. L., Chen, P. C., et al. (2007). Lower low-density lipoprotein cholesterol levels are associatedwithParkinson’s disease. Mov. Disord. 22, 377-381.doi:10.1002/mds.21290
52. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. A., et al.. The precursor protein of non-A component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475.doi:10.1016/0896-6273(95)90302-X
53. Iwasawa, R., Mahul-Mellier, A.-L., Datler, C., Pazarentzos, E., and Grimm, S.. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 30, 556-568.doi:10.1038/emboj.2010.346
54. Jao, C.C., Der-Sarkissian, A., Chen, J., and Langen, R. (2004). Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. Proc. Natl. Acad. Sci. US A 101, 8331-8336.doi:10.1073/pnas.0400553101
55. Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., and Langen, R. (2008). Structure ofmembrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc. Natl. Acad. Sci. USA 105, 19666-19671.doi:10.1073/pnas.0807826105
56. Jenner, P. (2003). Oxidative stress in Parkinson’s disease. Ann. Neurol. 53(Suppl. 3), S26-S36; discussion S36-S38.doi:10.1002/ana.10483
57. Kahle, P. J., Neumann, M., Ozmen, L., Muller, V., Jacobsen H., Schindzielorz, et al. (2000). Subcellular localization of wild-type and Parkinson’s disease- associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365-6373.
58. Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B., et al. (2010). Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29, 3571-3589.doi:10.1038/emboj.2010.223
59. Kidd, P.M. (2000). Parkinson’s disease as multifactorial oxidative neurodegeneration: Implications for integrative management. Altern. Med. Rev. 5, 502-529.
60. Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., and Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518-520.doi:10.1038/ng1778
61. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., et al. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat. Genet. 18, 106-108.doi:10.1038/ng0298-106
62. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.doi:10.1126/science.6823561
63. Lee, H.-J., Choi, C., and Lee, S.-J. (2002). Membrane-bound a-synuclein has ahigh aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678.doi:10.1074/jbc.m107045200
64. Lee, H.-J., Khoshaghideh, F., Lee, S., and Lee, S.-J. (2006). Impairment of microtubule-dependent trafficking by overexpression of a-synuclein. Eur. J. Neurosci. 24, 3153-3162.doi:10.1111/j.1460-9568.2006.05210.x
65. Levine, T., and Rabouille, C. (2005). Endoplasmic reticulum: One continuous network compartmentalized by extrinsic cues. Curr. Opin. Cell Biol. 17, 362-368.doi:10.1016/j.ceb.2005.06.005
66. Li, W.-W., Yang, R., Guo, J.-C., Ren, H.-M., Zha, X.-L., Cheng, J.-S., et al. (2007). Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport18, 1543-1546.doi:10.1097/wnr.0b013e3282f03db4
67. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988). Synuclein: A neuron- specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
68. Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., et al.. Parkinson’s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41-50.doi:10.1523/jneurosci.4308-05.2006
69. Masliah, E., Iwai, A., Mallory, M., Ueda, K., and Saitoh, T. (1996). Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer’s disease. Am. J. Pathol. 148, 201-210.
70. Mavlyutov, T. A., Epstein, M. L., Liu, P., Verbny, Y. I., Ziskind-Conhaim, L., and Ruoho, A. E. (2012). Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N/-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neuroscience 206, 60-68.doi:10.1016/j.neuroscience.2011.12.040
71. McNulty, J. A. (1980). Ultrastructural obsevations on synaptic ribbons in the pineal organ of the goldfish. Cell Tissue Res. 210, 249-256.doi:10.1007/bf00237613
72. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., and Lee, V. M. (2000). Synucleins are developmentally expressed and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220.
73. Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., et al. (2011). Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein a-synuclein. J. Biol. Chem. 286, 20710-20726.doi:10.1074/jbc.M110.213538
74. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., et al. (1999). Both familial Parkinson’s disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274, 9843-9846.doi:10.1074/jbc.274.14.9843
75. Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., and Wolozin, (2000). The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 6048-6054.
76. Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M., and Ghafourifar, P. (2008). Mitochondrial association of alpha-synuclein causes oxidative stress. Cell. Mol. Life Sci. 65, 1272-1284.doi:10.1007/s00018-008-7589-1
77. Parkinson, J. (2002). An essay on the shaking palsy. 1817. J. Neuropsychiatry Clin. Neurosci. 14, 223-236; discussion 222.doi:10.1176/appi.neuropsych.14.2.223
78. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045-2047.doi:10.1126/science.276.5321.2045
79. Rizzuto, R., Marchi, S., Bonora, M., Aguiari, P., Bononi, A., De Stefani, D., et al.Ca(2+) transfer from the ER to mitochondria: When, how and why. Biochim. Biophys. Acta 1787, 1342-1351.doi:10.1016/j.bbabio.2009.03.015
80. Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., et al. (1998). Close contacts with the endoplasmic reticulum as determinants ofmitochondrial Ca2+ responses. Science 280, 1763-1766.doi:10.1126/science.280.5370.1763
81. Ross, B. M., Mamalias, N., Moszczynska, A., Rajput, A. H., and Kish, S. J. (2001). Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson’s disease. Neuroscience 102, 899-904.doi:10.1016/s0306-4522(00)00501-7
82. Rowland, A. A., and Voeltz, G. K. (2012). Endoplasmic reticulum-mitochondria contacts: Function of thejunction. Nat. Rev. Mol. CellBiol. 13, 607-625.doi:10.1038/nrm3440
83. Rusinol, A. E., Cui, Z., Chen, M. H., and Vance, J. E. (1994). A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269, 27494-27502.
84. Sampaio-Marques, B., Felgueiras, C., Silva, A., Rodrigues, M., Tenreiro, S., Franssens, V., et al. (2012). SNCA (a-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy 8, 1494-1509.doi:10.4161/auto.21275
85. Schon, E. A., and Przedborski, S. (2011). Mitochondria: The next (neurode)generation. Neuron 70, 1033-1053.doi:10.1016/j.neuron.2011.06.003
86. Shavali, S., Brown-Borg, H. M., Ebadi, M., and Porter, J. (2008). Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci. Lett. 439, 125-128.doi:10.1016/j.neulet.2008.05.005
87. Simons, K., and Toomre, D. (2000). Lipid rafts and signal transduction. Nat. Rev. Mol. CellBiol. 1, 31-39.doi:10.1038/35036052
88. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). a-Synuclein locus triplication causes Parkinson’s disease. Science 302:841.doi:10.1126/science.1090278
89. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998). a-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U S A 95, 6469-6473.doi:10.1073/pnas.95.11.6469
90. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). a-synuclein in Lewy bodies. Nature 388, 839-840.doi:10.1038/42166
91. Tabas, I., and Ron, D. (2011). Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184-190.doi:10.1038/ncb0311-184
92. Taxi, J., and Eugene, D. (1995). Effects of axotomy, deafferentation and reinnervation on sympathetic ganglionic synapses: A comparative study. Int. Rev. Cytol. 159, 195-263.doi:10.1016/s0074-7696(08)62108-7
93. Twig, G., and Shirihai, O.S. (2011). The interplaybetween mitochondrial dynamics and mitophagy. Antioxid. Redox Signal. 14, 1939-1951.doi:10.1089/ars.2010.3779
94. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., et al. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 11282-11286.doi:10.1073/pnas.90.23.11282
95. Vance, J. E. (1990). Phospholipid synthesis in a membrane fraction associated with mitochondria. J. Biol. Chem. 265, 7248-7256.
96. Wang, X., Su, B., Fujioka, H., and Zhu, X. (2008). Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients. Am. J. Pathol. 173, 470-482.doi:10.2353/ajpath.2008.071208
97. Wang, X., Su, B., Zheng, L., Perry, G., Smith, M. A., and Zhu, X. (2009). The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J. Neurochem. 109(Suppl. 1), 153-159.doi:10.1111/j.1471-4159.2009.05867.x
98. Watanabe, H., and Burnstock, G. (1976). Junctional subsurface organs in frog sympathetic ganglion cells. J. Neurocytol. 5, 125-136.doi:10.1007/bf01176186
99. Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., and Selkoe, D. J.. Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48, 2045-2052.doi:10.1021/bi8019178
100. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., and Mizuno, Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93, 2696-2701.doi:10.1073/pnas.93.7.2696
101. Yu, W., Sun, Y., Guo, S., and Lu, B. (2011). The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum. Mol. Genet. 20, 3227-3240.doi:10.1093/hmg/ddr235
102. Zarranz, J. J., Alegre, J., Gomez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., et al. (2004). The new mutation, E46K, of a-synuclein causes Parkinson and Lewybodydementia. Ann. Neurol. 55, 164-173.doi:10.1002/ana.10795
103. Zhang, L., Zhang, C., Zhu, Y., Cai, Q., Chan, P., Ueda, K., et al. (2008). Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic studyusingaC-terminal specific monoclonal antibody. Brain Res. 1244, 40-52.doi:10.1016/j.brainres.2008.08.067
104. Zigoneanu, I. G., Yang, Y. J., Krois, A. S., Haque, M. E., and Pielak, G. J. (2012). Interaction of a-synuclein with vesicles that mimic mitochondrial membranes. Biochim. Biophys. Acta 1818, 512-519.doi:10.1016/j.bbamem.2011.11.024